Literature DB >> 15497685

Phase behavior of amorphous molecular dispersions I: Determination of the degree and mechanism of solid solubility.

Madhav Vasanthavada1, Wei-Qin Tong, Yatindra Joshi, M Serpil Kislalioglu.   

Abstract

PURPOSE: To understand the phase behavior and the degree and mechanism of the solid solubility in amorphous molecular dispersions by the use of thermal analysis.
METHODS: Amorphous molecular dispersions of trehalose-dextran and trehalose-PVP were prepared by co-lyophilization. The mixtures were exposed to 23 degrees C, 40 degrees C, and 50 degrees C [75% relative humidity (RH)] and 23 degrees C (69% RH) storage conditions, respectively. Thermal analysis was conducted by modulated differential scanning calorimeter (MDSC).
RESULTS: Upon exposure to moisture, two glass transition temperatures (TgS), one for phase-separated amorphous trehalose (Tg1) and the other for polymer-trehalose mixture (Tg2), were observed. With time, Tg2 increased and reached to a plateau (Tg(eq)), whereas Tg1 disappeared. The disappearance of Tg1 was attributed to crystallization of the phase-separated amorphous trehalose. It was observed that Tg(eq) was always less than Tg of pure polymer. The lower Tg(eq) when compared to Tg of pure polymer may be the result of solubility of a fraction of trehalose in the polymers chosen. The miscible fraction of trehalose was estimated to be 12% and 18% wt/wt in dextran at 50 degrees C/75% RH and 23 degrees C/75% RH, respectively, and 10% wt/wt in PVP at 23 degrees C/69% RH.
CONCLUSIONS: Mixing behavior of trehalose-dextran and trehalose-PVP dispersions were examined both experimentally and theoretically. A method determining the "extent of molecular miscibility," referred to as "solid solubility," was developed and mechanistically and thermodynamically analyzed. Solid dispersions prepared at trehalose concentrations below the "solid solubility limit" were physically stable even under accelerated stability conditions.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15497685     DOI: 10.1023/b:pham.0000041454.76342.0e

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  16 in total

1.  Relationship between the crystallization rates of amorphous nifedipine, phenobarbital, and flopropione, and their molecular mobility as measured by their enthalpy relaxation and (1)H NMR relaxation times.

Authors:  Y Aso; S Yoshioka; S Kojima
Journal:  J Pharm Sci       Date:  2000-03       Impact factor: 3.534

2.  The measurement of small quantities of amorphous material--should we be considering the rigid amorphous fraction?

Authors:  D Q Craig; V L Kett; J R Murphy; D M Price
Journal:  Pharm Res       Date:  2001-08       Impact factor: 4.200

Review 3.  How does residual water affect the solid-state degradation of drugs in the amorphous state?

Authors:  E Y Shalaev; G Zografi
Journal:  J Pharm Sci       Date:  1996-11       Impact factor: 3.534

4.  Mixing behavior of colyophilized binary systems.

Authors:  S L Shamblin; L S Taylor; G Zografi
Journal:  J Pharm Sci       Date:  1998-06       Impact factor: 3.534

5.  Physical properties of solid molecular dispersions of indomethacin with poly(vinylpyrrolidone) and poly(vinylpyrrolidone-co-vinyl-acetate) in relation to indomethacin crystallization.

Authors:  T Matsumoto; G Zografi
Journal:  Pharm Res       Date:  1999-11       Impact factor: 4.200

6.  The effect of temperature on hydrogen bonding in crystalline and amorphous phases in dihydropyrine calcium channel blockers.

Authors:  Xiaolin Charlie Tang; Michael J Pikal; Lynne S Taylor
Journal:  Pharm Res       Date:  2002-04       Impact factor: 4.200

7.  Sugar-polymer hydrogen bond interactions in lyophilized amorphous mixtures.

Authors:  L S Taylor; G Zografi
Journal:  J Pharm Sci       Date:  1998-12       Impact factor: 3.534

8.  Crystallization inhibition in solid dispersions of MK-0591 and poly(vinylpyrrolidone) polymers.

Authors:  K Khougaz; S D Clas
Journal:  J Pharm Sci       Date:  2000-10       Impact factor: 3.534

9.  Characterization of solid dispersions of itraconazole and hydroxypropylmethylcellulose prepared by melt extrusion, Part II.

Authors:  Karel Six; Hugo Berghmans; Christian Leuner; Jennifer Dressman; Kristof Van Werde; Jules Mullens; Luc Benoist; Mireille Thimon; Laurent Meublat; Geert Verreck; Jef Peeters; Marcus Brewster; Guy Van den Mooter
Journal:  Pharm Res       Date:  2003-07       Impact factor: 4.200

10.  Inhibition of indomethacin crystallization in poly(vinylpyrrolidone) coprecipitates.

Authors:  M Yoshioka; B C Hancock; G Zografi
Journal:  J Pharm Sci       Date:  1995-08       Impact factor: 3.534

View more
  13 in total

Review 1.  Amorphous solid dispersion technique for improved drug delivery: basics to clinical applications.

Authors:  Dinesh Kumar Mishra; Vinod Dhote; Arpit Bhargava; Dinesh Kumar Jain; Pradyumna Kumar Mishra
Journal:  Drug Deliv Transl Res       Date:  2015-12       Impact factor: 4.617

Review 2.  Sustained-release amorphous solid dispersions.

Authors:  Julien Maincent; Robert O Williams
Journal:  Drug Deliv Transl Res       Date:  2018-12       Impact factor: 4.617

3.  Phase behavior of amorphous molecular dispersions II: Role of hydrogen bonding in solid solubility and phase separation kinetics.

Authors:  Madhav Vasanthavada; Wei-Qin Tong; Yatindra Joshi; M Serpil Kislalioglu
Journal:  Pharm Res       Date:  2005-03       Impact factor: 4.200

4.  Probing the Interplay between Amorphous Solid Dispersion Stability and Polymer Functionality.

Authors:  Derek S Frank; Adam J Matzger
Journal:  Mol Pharm       Date:  2018-06-20       Impact factor: 4.939

5.  Screening methodologies for the development of spray-dried amorphous solid dispersions.

Authors:  Íris Duarte; José Luís Santos; João F Pinto; Márcio Temtem
Journal:  Pharm Res       Date:  2014-08-19       Impact factor: 4.200

6.  Solubility of small-molecule crystals in polymers: D-mannitol in PVP, indomethacin in PVP/VA, and nifedipine in PVP/VA.

Authors:  Jing Tao; Ye Sun; Geoff G Z Zhang; Lian Yu
Journal:  Pharm Res       Date:  2008-12-04       Impact factor: 4.200

7.  PLGA and PHBV microsphere formulations and solid-state characterization: possible implications for local delivery of fusidic acid for the treatment and prevention of orthopaedic infections.

Authors:  Chiming Yang; David Plackett; David Needham; Helen M Burt
Journal:  Pharm Res       Date:  2009-04-21       Impact factor: 4.200

8.  Qualitative and Quantitative Characterization of Composition Heterogeneity on the Surface of Spray Dried Amorphous Solid Dispersion Particles by an Advanced Surface Analysis Platform with High Surface Sensitivity and Superior Spatial Resolution.

Authors:  Sonal V Bhujbal; Dmitry Y Zemlyanov; Alex Cavallaro; Sharad Mangal; Lynne S Taylor; Qi Tony Zhou
Journal:  Mol Pharm       Date:  2018-04-17       Impact factor: 4.939

9.  Role of P-Glycoprotein Inhibitors in the Bioavailability Enhancement of Solid Dispersion of Darunavir.

Authors:  Saleha Rehman; Bushra Nabi; Mohammad Fazil; Saba Khan; Naimat Kalim Bari; Romi Singh; Shavej Ahmad; Varinder Kumar; Sanjula Baboota; Javed Ali
Journal:  Biomed Res Int       Date:  2017-10-31       Impact factor: 3.411

10.  Soluplus-Mediated Diosgenin Amorphous Solid Dispersion with High Solubility and High Stability: Development, Characterization and Oral Bioavailability.

Authors:  Pei Liu; Jian-Yu Zhou; Jin-Hua Chang; Xi-Gang Liu; He-Fei Xue; Ru-Xing Wang; Zhong-Si Li; Chun-Shi Li; Jian Wang; Cui-Zhe Liu
Journal:  Drug Des Devel Ther       Date:  2020-07-27       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.